Yi Ling

1.6k total citations · 2 hit papers
16 papers, 1.2k citations indexed

About

Yi Ling is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yi Ling has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yi Ling's work include Pulmonary Hypertension Research and Treatments (5 papers), Tryptophan and brain disorders (4 papers) and Gut microbiota and health (4 papers). Yi Ling is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Tryptophan and brain disorders (4 papers) and Gut microbiota and health (4 papers). Yi Ling collaborates with scholars based in China, United Kingdom and Ireland. Yi Ling's co-authors include Jing Sun, Jiaming Liu, Tianyu Gong, Fangyan Wang, Shiqing Ye, Joanna Pepke‐Żaba, Andrew J. Peacock, Karen Sheares, Martin Johnson and Changwei Yang and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Yi Ling

16 papers receiving 1.2k citations

Hit Papers

Changing Demographics, Epidemiology, and Survival of Inci... 2012 2026 2016 2021 2012 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Ling China 9 511 500 341 308 270 16 1.2k
Wenqian Chen China 14 362 0.7× 92 0.2× 134 0.4× 90 0.3× 37 0.1× 66 834
Marlene E. Starr United States 19 260 0.5× 85 0.2× 58 0.2× 254 0.8× 25 0.1× 33 1.2k
Kentaro Watanabe Japan 16 134 0.3× 148 0.3× 155 0.5× 122 0.4× 28 0.1× 132 989
Allison E. Norlander United States 15 249 0.5× 96 0.2× 370 1.1× 259 0.8× 23 0.1× 25 1.6k
Norbert J. Tripolt Austria 15 352 0.7× 134 0.3× 78 0.2× 355 1.2× 16 0.1× 45 854
Thomas Dschietzig Germany 26 278 0.5× 162 0.3× 430 1.3× 227 0.7× 42 0.2× 65 1.9k
Elko Randrianarisoa Germany 12 311 0.6× 61 0.1× 131 0.4× 269 0.9× 24 0.1× 23 820
Steven L. Rabinowe United States 20 134 0.3× 47 0.1× 268 0.8× 147 0.5× 17 0.1× 32 1.1k
Marianna Conte Italy 7 116 0.2× 122 0.2× 171 0.5× 81 0.3× 16 0.1× 7 645

Countries citing papers authored by Yi Ling

Since Specialization
Citations

This map shows the geographic impact of Yi Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ling more than expected).

Fields of papers citing papers by Yi Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ling. The network helps show where Yi Ling may publish in the future.

Co-authorship network of co-authors of Yi Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ling. A scholar is included among the top collaborators of Yi Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ling. Yi Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sun, Jing, Xinxin Gao, Zewei Chen, et al.. (2020). The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke. Neuroscience Letters. 734. 135098–135098. 20 indexed citations
2.
Ling, Yi, Tianyu Gong, Junmei Zhang, et al.. (2020). Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke. Frontiers in Aging Neuroscience. 12. 511562–511562. 65 indexed citations
3.
4.
Peacock, Andrew J., Yi Ling, Martin Johnson, et al.. (2020). Idiopathic pulmonary arterial hypertension and co‐existing lung disease: is this a new phenotype?. Pulmonary Circulation. 10(1). 1–8. 17 indexed citations
5.
Lin, Haihong, et al.. (2019). Therapeutic effects of erythropoietin expressed in mesenchymal stem cells for dilated cardiomyopathy in rat. Biochemical and Biophysical Research Communications. 517(4). 575–580. 5 indexed citations
6.
Ling, Yi, et al.. (2019). Gallstone Disease is an Independent Predictor for Poststroke Cognitive Impairment in Young Patients with Acute Ischemic Stroke. European Neurology. 82(1-3). 15–22. 4 indexed citations
7.
Sun, Jing, Jing‐Xuan Xu, Yi Ling, et al.. (2019). Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice. Translational Psychiatry. 9(1). 388 indexed citations breakdown →
8.
Sun, Jing, Suzhi Liu, Zongxin Ling, et al.. (2019). Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through Modulating Gut Microbiota. Journal of Agricultural and Food Chemistry. 67(10). 3006–3017. 120 indexed citations
9.
Ling, Yi, et al.. (2017). Low dose Cyclosporin A treatment increases live birth rate of unexplained recurrent abortion - initial cohort study. Clinical and Experimental Obstetrics & Gynecology. 44(2). 230–235. 28 indexed citations
10.
Gong, Hui, et al.. (2016). Correlation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunction. Experimental and Therapeutic Medicine. 11(6). 2583–2589. 4 indexed citations
11.
Gong, Hui, et al.. (2014). Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function. Experimental and Therapeutic Medicine. 7(6). 1506–1512. 8 indexed citations
12.
Ling, Yi, Martin Johnson, David G. Kiely, et al.. (2012). Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. American Journal of Respiratory and Critical Care Medicine. 186(8). 790–796. 392 indexed citations breakdown →
13.
Ling, Yi, et al.. (2012). Predicting survival in pulmonary arterial hypertension in the UK. European Respiratory Journal. 40(3). 604–611. 89 indexed citations
15.
Tian, Lulu, et al.. (2011). A sensitive and specific HPLC–MS/MS analysis and preliminary pharmacokinetic characterization of isoforskolin in beagle dogs. Journal of Chromatography B. 879(31). 3688–3693. 7 indexed citations
16.
Ling, Yi, Martin Johnson, David G. Kiely, et al.. (2011). Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. 38. 4909. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026